Scratching an itchy rash worsens inflammation by triggering pain-sensing neurons and activating mast cells, creating a ...
The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
AS 2025 dawned a new way of life was beginning for Paul Flanagan, as for the first time in his adult life he would not be ...
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx ...
The full-circle moment is not lost on newly appointed Illawarra Rugby League head of football Brad Hughes.